Cargando…

Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy

During the cell cycle, DNA suffers several lesions that need to be repaired prior to entry into mitosis to preserve genome integrity in daughter cells. Toward this aim, cells have developed complex enzymatic machinery, the so-called DNA damage response (DDR), which is able to repair DNA, temporarily...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Francesca, Giuffrida, Raffaella, Raciti, Gabriele, Puglisi, Caterina, Forte, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508993/ https://www.ncbi.nlm.nih.gov/pubmed/34639030 http://dx.doi.org/10.3390/ijms221910689

Ejemplares similares

Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer
por: Kim, Hye-Young, et al.
Publicado: (2016)

WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
por: Zheng, Hongping, et al.
Publicado: (2017)

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
por: Bukhari, Amirali B., et al.
Publicado: (2022)

Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer
por: Giuffrida, Dario, et al.
Publicado: (2019)

Metabolic complete tumor response in a patient with epidermal growth factor receptor mutant non-small cell lung cancer treated with a reduced dose of afatinib
por: Puliafito, Ivana, et al.
Publicado: (2022)

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
por: Mancini, Manuela, et al.
Publicado: (2022)

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
por: Lee, Yoo-Young, et al.
Publicado: (2019)

Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis
por: Hanna, Carol B, et al.
Publicado: (2020)

Rescue from granzyme B-induced apoptosis by Wee1 kinase
Publicado: (1995)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2018)

Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment
por: Ye, Shuai, et al.
Publicado: (2021)

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines
por: Iannuzzi, Carmelina Antonella, et al.
Publicado: (2020)

Radiosensitivity of Cancer Stem Cells Has Potential Predictive Value for Individual Responses to Radiotherapy in Locally Advanced Rectal Cancer
por: Puglisi, Caterina, et al.
Publicado: (2020)

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance
por: Serra, Violeta, et al.
Publicado: (2022)

Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells
por: Kogiso, Tomomi, et al.
Publicado: (2014)

Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells
por: Pappano, William N, et al.
Publicado: (2014)

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
por: Harris, Peter S, et al.
Publicado: (2014)

Air raids and the 'Wee' Hospital.
por: Logan, C. J. H.
Publicado: (2003)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
por: Dasari, Santosh K., et al.
Publicado: (2023)

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
por: Magnussen, Gry Irene, et al.
Publicado: (2012)

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
por: Lin, Hui-Ming, et al.
Publicado: (2021)

Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo
por: Puglisi, Caterina, et al.
Publicado: (2022)

Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
por: Schmidt, Matthias, et al.
Publicado: (2017)

WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma
por: Ponce, Rovingaile Kriska M., et al.
Publicado: (2022)

Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders
por: Alli, Vidya Jyothi, et al.
Publicado: (2023)

Oocyte-specific Wee1-like protein kinase 2 is dispensable for fertility in mice
por: Nozawa, Kaori, et al.
Publicado: (2023)

Carbon Dots as Promising Tools for Cancer Diagnosis and Therapy
por: Nocito, Giuseppe, et al.
Publicado: (2021)

Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
por: Lindell, Emma, et al.
Publicado: (2023)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021)

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
por: Puliafito, Ivana, et al.
Publicado: (2022)

Potential Role of Activating Transcription Factor 5 during Osteogenesis
por: Vicari, Luisa, et al.
Publicado: (2016)

Not so WEE: Targeting G(2)/M to kill mesothelioma cells
por: Dent, Paul
Publicado: (2014)

Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition
por: van Harten, Anne M., et al.
Publicado: (2020)

A Wee Lesson in Science Communication
por: King, Emma
Publicado: (2004)

Pedicures, wees alert op ‘coronatenen’
por: van Putten, Margreet
Publicado: (2020)

WEE1 Inhibitor: Clinical Development
por: Kong, Anthony, et al.
Publicado: (2021)

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
por: Bell, Hayden L., et al.
Publicado: (2023)

Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry
por: Fasulo, Barbara, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fbm6fllj3svu0fiuq41kpq99v8